Key facts: Certara Bookings Up 4%; Losses Widen; Phoenix Cloud 10%

Certara (CERT) reported Q3 bookings up 4% to $92.5M, with software bookings rising 15%. Losses widened due to higher operating costs, but adjusted EBITDA was $83.1M. Phoenix cloud conversions are ahead of schedule, though may impact near-term revenue.

Original reporting
Published Nov 6, 2026, 8:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 8:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Key facts: Certara Bookings Up 4%; Losses Widen; Phoenix Cloud 10% — source image
Decision brief

The 30-second read

$CERTBearishMed
01

Why it matters

The mixed results could lead to short‑term price weakness but may set up longer‑term upside if cloud adoption accelerates.

02

Market read

First report of Q3 bookings and loss widening for Certara, offering fresh data for traders.

03

What to watch

Cloud migration could improve margins long‑term; current loss widening may be temporary.

Relevance 6/10Novelty 6/10Timing: pre‑market

Background

Certara is a provider of software and services for the life‑sciences industry.

Company-level read

Ticker impact

$CERTBearishMedium confidence
Context

Certara reported Q3 bookings up 4% to $92.5M but wider losses, marking the first disclosure of these figures.

Expected impact

downward pressure as investors digest higher losses despite booking increase

Evidence & confidence

Bookings growth is modest and cloud transition may delay revenue, while loss widening signals cost pressure.

Market effects

Signals potential slowdown in biotech software services revenue growth.

Limited to US biotech/software niche.

Low, as Certara is a small‑cap with niche exposure.

Counterpoint

Investors may view the booking increase as a positive tailwind despite losses.

Key entities

  • Certara, Inc.

    Life‑sciences software and services provider.

Related articles

$CERTMedAI 8/10

An Idle Mill and Old Open Pits Draw a New Plan in Southern Argentina

Cerrado Gold Inc. (TSX.V: CERT) (OTCQX: CRDOF) acquired a past-producing mine in Argentina for $20M, aiming to restart operations by 2027. The mine previously produced 1.4M gold equivalent ounces, with peak output of 137,500 ounces in 2011. The company plans a $40,000m drill program for a resource estimate, funded by its existing Santa Cruz operation.

$CERTHigh

Certara Software Revenue Jumps 11% as Services Decline

Certara Inc. (CERT) reported Q3 2026 software revenue growth of 11% to $48.8M, while services revenue declined 2% to $46.1M. Total revenue rose 4% to $94.9M, and net loss narrowed to $3.6M. Adjusted EBITDA increased 6% to $30.2M. The company maintained its full-year revenue growth forecast of 2-3% and updated its adjusted earnings outlook to 31-34 cents per share.

$CERTMed

Why Did Certara (CERT) Shares Climb After Its Latest Update?

Certara (CERT) reported Q3 2026 revenue of $94.9M, up from $90.89M a year earlier, with net income of $5.59M. However, nine-month revenue of $282.26M showed a net loss of $58.44M. Shares rose 9.83% in one day and 35.94% in 30 days, with a year-to-date return of 39.36%. The company's fair value is estimated at $8.71, suggesting a 40% overvaluation. Certara's AI-driven platforms and acquisitions aim to boost revenue and margins.

$CERTMed

Certara Inc (CERT) Q3 2026 Earnings Call Highlights: Software Growth Accelerates as Margins Expand

Certara Inc (CERT) reported Q3 2026 earnings with software revenue growth of 11% but services revenue declined 2% YoY to $46.1M. Full-year 2026 revenue growth guidance was narrowed to 2%-3%. CEO Jon Resnick highlighted cost savings exceeding $12M and strong software demand across customer tiers. The company is transitioning to a cloud-based model and investing in AI initiatives, expecting growth in 2027. GAAP net loss was $3.6M, and adjusted EPS remained flat at $0.09 YoY.

$CERTMed

Certara, Inc. Q3 2026 Earnings Call Summary

Certara reported 11% organic software revenue growth in Q3 2026, its first double-digit increase in two years. The company divested its Regulatory and Medical Writing business to focus on high-growth areas and reorganized operations. Management expects 2%-3% full-year revenue growth, with software outperforming services. AI capabilities and APAC market expansion are seen as growth drivers for 2027.